Chujiao Hu

2PUBLICATIONS
4CO-AUTHORS
Instrumental methods (excl. immunological and bioassay methods)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 27, 2026
AS-TLC-Based High-Throughput Screening Integrated with CuAAC Optimization Strategy Facilitates the Rapid Discovery of YTHDC1 Inhibitor.

|Feb 16, 2026
CRISPR-Cas9 screening identifies ATOX1-driven cisplatin resistance mechanisms in liver cancer and evaluates targeted inhibitor efficacy.

Chujiao Hu, Huading Tai, Renguang Zhu

Pageof 1

Frequent Collaborators

1 joint publications

Zhirui Zeng

1 joint publications

Huan Xiong

1 joint publications

Cheng Luo

1 joint publications

Shijie Chen